Anbang Biotech (7784-TW) has entered into a research cooperation agreement with the Veterinary Surgery Laboratory of the Graduate School of Agricultural and Life Sciences, University of Tokyo. Under this agreement, Anbang and the university will work together to evaluate the efficacy of Anbang's ABT-301 in treating multiple solid tumors using veterinary oncology models. The goal is to expand the human clinical indications for ABT-301 through these evaluations.